NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that it has filed a Premarket Approval Supplement (PMA-S) ...
Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...
Nicola Swanborough, Head of External Affairs at Epilepsy Society said: “We welcome this much-needed overhaul which prioritises treatment for patients with urgent and complex dental requirements. This ...
GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.
Researchers at the Netherlands Institute for Neuroscience have become the first to fully characterize cell activity from a ...
This new program from Norton Hospital aims to bridge the gap between pediatric and adult care for those with ...
Tampa Free Press on MSN
Feds In Michigan Dismantle ‘E-Note’ Crypto Empire, Charge Russian Man In $70M Laundering Operation
A major digital pipeline used by cybercriminals to "wash" illicit funds has been severed following a coordinated ...
A patient controls a robotic dog during the BCI clinical trail. Photo: Courtesy of the CEBSIT. The Global Times learned on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback